Lebrikizumab Improves Atopic Dermatitis and ​Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab: ​ Results From the ADapt Trial. (2025). SKIN The Journal of Cutaneous Medicine, 9(1), s512. https://doi.org/10.25251/skin.9.supp.512